Skip to main content

Table 2 Prevalence of metabolic syndrome among groups

From: Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria

Treatment

Prevalence

P-value

1st Line drug treatment

15/62 (24.2%)

 

2nd Line drug treatment

5/50 (10%)

0.022*

Naïve

7/61 (11.5%)

 

Controls

4/50 (8%)

χ2 = 9.6

Overall prevalence

31/223 (13.9%)

 
  1. *Statistically significant.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us